Myelodysplastic syndrome medical therapy: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
(Mahshid) |
||
| (11 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}};{{AE}}{{NM}} | {{CMG}};{{AE}}{{NM}} | ||
==Overview== | ==Overview== | ||
==Medical | [[Chemotherapy]] is recommended among all patients who develop myelodysplastic syndrome.<ref name=cancerca>Treatment of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.ca/en/cancer-information/cancer-type/leukemia/leukemia/myelodysplastic-syndromes/?region=on. Accessed on December 15, 2015</ref> | ||
Treatment is based on the type of | ==Medical Therapy== | ||
*Relieve symptoms | *Treatment is based on the type of myelodysplastic syndrome and the person's age and general health. The goal of treatment for myelodysplastic syndrome is to:<ref name=cancerca>Treatment of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.ca/en/cancer-information/cancer-type/leukemia/leukemia/myelodysplastic-syndromes/?region=on. Accessed on December 15, 2015</ref> | ||
*Slow or prevent progression of the disease | **Relieve symptoms | ||
*Improve quality of life | **Slow or prevent progression of the disease | ||
**Improve quality of life | |||
===Chemotherapy=== | ===Chemotherapy=== | ||
*The most common chemotherapy drug used to treat myelodysplastic syndrome is cytarabine. Cytarabine may be combined with other pharmacological agents such as:<ref name=cancerca>Treatment of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.ca/en/cancer-information/cancer-type/leukemia/leukemia/myelodysplastic-syndromes/?region=on. Accessed on December 15, 2015</ref> | |||
The most common chemotherapy drug used to treat | **[[Idarubicin]] | ||
**[[Topotecan]] | |||
*Idarubicin | **[[Fludarabine]] | ||
* Other chemotherapeutic agents that may be used to treat myelodysplastic syndrome include:<ref name=cancerca>Treatment of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.ca/en/cancer-information/cancer-type/leukemia/leukemia/myelodysplastic-syndromes/?region=on. Accessed on December 15, 2015</ref> | |||
*Topotecan | **[[Daunorubucin]] | ||
**[[Mitoxantrone]] | |||
*Fludarabine | ===Supportive Therapy=== | ||
*Supportive therapy is given to relieve symptoms and lessen the problems caused by abnormal blood cell counts or treatment for myelodysplastic syndrome.<ref name=cancerca>Treatment of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.ca/en/cancer-information/cancer-type/leukemia/leukemia/myelodysplastic-syndromes/?region=on. Accessed on December 15, 2015</ref> | |||
Other | |||
*Daunorubucin | |||
*Mitoxantrone | |||
===Supportive | |||
Supportive therapy is given to relieve symptoms and lessen the problems caused by abnormal blood cell counts or treatment for | |||
====Transfusions==== | ====Transfusions==== | ||
*Patients with anemia may receive blood transfusions to correct the red blood cell counts. | |||
*Frequent blood transfusions can be complicated by a buildup of extra iron in the body, which is treated with drug therapy. | |||
*Patients with bleeding problems due to low platelet counts may be given platelet transfusions. | |||
Frequent blood transfusions can | ====Growth Factors==== | ||
*[[Epoetin]] (erythropoietin) | |||
====Growth | |||
*Epoetin ( | |||
:*Helps improve production of red blood cells | :*Helps improve production of red blood cells | ||
*[[Filgrastim]] | |||
*Filgrastim | |||
:*Also called granulocyte colony-stimulating factor (G-CSF) | :*Also called granulocyte colony-stimulating factor (G-CSF) | ||
:*Helps improve production of white blood cells | :*Helps improve production of white blood cells | ||
*[[Pegfilgrastim]] | |||
*Pegfilgrastim | |||
:*A long-acting G-CSF | :*A long-acting G-CSF | ||
==== | ====Supportive Therapy==== | ||
*Other drugs that may be used to treat symptoms or side effects of therapy include:<ref name=cancerca>Treatment of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.ca/en/cancer-information/cancer-type/leukemia/leukemia/myelodysplastic-syndromes/?region=on. Accessed on December 15, 2015</ref> | *Other drugs that may be used to treat symptoms or side effects of therapy include:<ref name=cancerca>Treatment of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.ca/en/cancer-information/cancer-type/leukemia/leukemia/myelodysplastic-syndromes/?region=on. Accessed on December 15, 2015</ref> | ||
*[[Deferoxamine]] | |||
*Deferoxamine | |||
:*treats excess iron in the blood | :*treats excess iron in the blood | ||
:*sometimes given with Vitamin C. | :*sometimes given with Vitamin C. | ||
*[[Lenalidomide]] | |||
*Lenalidomide | |||
:*decreases the need for transfusions in people with a specific chromosome change | :*decreases the need for transfusions in people with a specific chromosome change | ||
*[[Antithymocyte globulin]] | |||
*Antithymocyte globulin | :*decreases the need for transfusions in certain types of myelodysplastic syndrome | ||
:*decreases the need for transfusions in certain types of | |||
*Antibiotics | *Antibiotics | ||
:*help to prevent or treat infections | :*help to prevent or treat infections | ||
*Hypomethylating agents, such as [[5-azacytidine]] or [[decitabine]] | |||
*Hypomethylating agents, such as 5-azacytidine or decitabine | |||
:*stop cancer cells from producing DNA or RNA so the cells die | :*stop cancer cells from producing DNA or RNA so the cells die | ||
==References== | ==References== | ||
{{reflist| | {{reflist|1}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
| Line 73: | Line 53: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 02:49, 27 November 2017
|
Myelodysplastic syndrome Microchapters |
|
Differentiating Myelodysplastic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myelodysplastic syndrome medical therapy On the Web |
|
American Roentgen Ray Society Images of Myelodysplastic syndrome medical therapy |
|
Risk calculators and risk factors for Myelodysplastic syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Chemotherapy is recommended among all patients who develop myelodysplastic syndrome.[1]
Medical Therapy
- Treatment is based on the type of myelodysplastic syndrome and the person's age and general health. The goal of treatment for myelodysplastic syndrome is to:[1]
- Relieve symptoms
- Slow or prevent progression of the disease
- Improve quality of life
Chemotherapy
- The most common chemotherapy drug used to treat myelodysplastic syndrome is cytarabine. Cytarabine may be combined with other pharmacological agents such as:[1]
- Other chemotherapeutic agents that may be used to treat myelodysplastic syndrome include:[1]
Supportive Therapy
- Supportive therapy is given to relieve symptoms and lessen the problems caused by abnormal blood cell counts or treatment for myelodysplastic syndrome.[1]
Transfusions
- Patients with anemia may receive blood transfusions to correct the red blood cell counts.
- Frequent blood transfusions can be complicated by a buildup of extra iron in the body, which is treated with drug therapy.
- Patients with bleeding problems due to low platelet counts may be given platelet transfusions.
Growth Factors
- Epoetin (erythropoietin)
- Helps improve production of red blood cells
- Also called granulocyte colony-stimulating factor (G-CSF)
- Helps improve production of white blood cells
- A long-acting G-CSF
Supportive Therapy
- Other drugs that may be used to treat symptoms or side effects of therapy include:[1]
- Deferoxamine
- treats excess iron in the blood
- sometimes given with Vitamin C.
- decreases the need for transfusions in people with a specific chromosome change
- decreases the need for transfusions in certain types of myelodysplastic syndrome
- Antibiotics
- help to prevent or treat infections
- Hypomethylating agents, such as 5-azacytidine or decitabine
- stop cancer cells from producing DNA or RNA so the cells die